Last Updated: October 2026
How do you conduct a TMF audit to be ready for an inspection? Define a risk-based scope, then review five areas: SOPs and content quality, oversight documentation, training compliance, adherence to plans, and team interviews. Check that documents are present, filed in the right place, timely, correctly indexed, and access-controlled, review eTMF audit trails, and close every finding with documented corrective action before inspectors arrive.
Below, we cover why a pre-inspection audit matters, the five areas to review, common pitfalls, how to close findings, and what to look for in a system.
In this article
- Why audit the TMF before an inspection
- 5 key areas to consider during your TMF audit
- Avoiding common pitfalls
- Closing the gap: addressing audit findings
- Spreadsheet review vs. eTMF-assisted audit
- Comparing eTMF options at a glance
- How Kivo supports inspection-ready TMFs
- Frequently asked questions
- Key takeaway
Conducting a Trial Master File (TMF) audit is an important aspect of maintaining the quality and integrity of clinical trial data, as well as preparing for inspections. In this article, we will explore five key areas that should be considered during a TMF audit to ensure inspection readiness.
Why Audit the TMF Before an Inspection
Inspectors judge the TMF as the record of how a trial was actually run, and the sponsor is expected to know its state before they do. The EMA's guideline on the content, management and archiving of the clinical TMF (adopted December 2018, effective June 2019) says sponsors and investigators should "implement risk-based quality checks (QC) or review processes" to confirm that essential documents are present, filed in the appropriate locations, added in a timely manner, correctly indexed, and accessible only according to assigned roles. For an eTMF, it also lists review of the audit trail as part of those checks (EMA, 2018).
The newer ICH E6(R3) good clinical practice guideline raises the bar on the same theme. It moves from "essential documents" to broader "essential records," keeps the sponsor responsible for activities delegated to service providers, and calls for risk-proportionate quality management. It took effect for clinical trials in the EU on July 23, 2025. A TMF audit is the practical way to show that your records, and your oversight of CROs and vendors, hold up against those expectations.
5 Key Areas to Consider During Your TMF Audit
1. Review SOPs and Evaluate TMF Content Quality
Start by reviewing the Standard Operating Procedures (SOPs) associated with the creation and management of TMF content. This will help outline what activities should have been taken and highlight those that may not have. In addition, this step helps ensure that the documented processes align with industry best practices and regulatory requirements. Don't forget to evaluate the quality of data and documentation in the various systems that support the trial. Look for completeness, accuracy, and consistency across all systems holding study data. Incomplete or inaccurate documentation can hinder the assessment of the trial's true state and study conduct. Real-time completeness reporting makes this far easier; see real-time TMF completeness metrics: what to track and why.
|
A Cautionary Tale: Prior to inspection, a study director did not conduct an audit of the TMF. In the resulting audit, the FDA found that the study director failed to assure that the protocol, including any changes, was approved as provided by 21 CFR § 58.120 and was followed; that all experimental data, including observations of unanticipated responses of the test system were accurately recorded and verified; and that unforeseen circumstances that may affect the quality and integrity of the nonclinical laboratory study were noted when they occur, and corrective action was taken and documented. Because they failed to ensure that all experimental data were accurately recorded and verified, and that all entries and changes in entries were properly documented, FDA had concerns about the integrity of the data generated from the nonclinical toxicity studies conducted. The entire study was called into question, and significantly delayed. Had this study director conducted a TMF audit prior to their inspection, the audit would likely have surfaced these issues! |
2. Assess Oversight Documentation
In addition to reviewing spreadsheets, it's important to assess oversight documentation such as communications and meeting minutes. These records provide insights into the activities conducted throughout the trial. By thoroughly evaluating oversight documentation, auditors can determine the level of compliance with study conduct using these essential documents. For what sponsor oversight requires from the system itself, see what an eTMF system needs for real sponsor oversight.
3. Evaluate Training Compliance
Conduct a comprehensive review of training for all study team members, including the CRO team. Verify that the training records are complete, up-to-date, and demonstrate adherence to the required training curriculum. Adequate training ensures that all team members have the necessary knowledge and skills to perform their roles effectively and in compliance with regulatory guidelines.
4. Ensure Compliance with Plans and Proper Documentation
One important aspect of a TMF audit is assessing evidence of adherence to various plans. It is essential to verify whether the trial activities followed the predetermined plans and if any deviations were clearly documented. Auditors should look for evidence that demonstrates compliance with protocols, consent forms, and other relevant study plans.
5. Interview Study Team Members and Assess TMF Contents
Interview study team members to gain insights into study events, deviations, and safety reports. These interviews help auditors assess whether the TMF contains evidence of the steps taken to address issues and ensure patient safety. The TMF should provide a comprehensive record of study-related activities, capturing all relevant information and actions taken.
For additional insight into how to conduct a TMF Audit, download the whitepaper.
Avoiding Common Pitfalls
With the complexity of trials and use of electronic systems, it is important to be aware of common pitfalls that organizations may encounter during inspection. By conducting a thorough audit as part of the inspection preparation, these gaps can be identified and addressed beforehand. Here are some common areas to appraise:
Incomplete or Inaccurate Documentation
Incomplete or inaccurate TMF documentation is one of the most common findings during TMF audits and inspections. If the TMF is missing key documents, or if the documents are incomplete or inaccurate, it can be difficult to determine the true state of the trial and study conduct. To avoid this, auditors should thoroughly review the TMF to ensure that all documents are complete, accurate, and consistent across all systems holding study data. Taking a risk-based approach can help prioritize documentation review based on its significance to the trial.
Poorly Defined Oversight Activities
Another common pitfall of TMFs is poorly defined requirements for conducting oversight of study activities. If the activities are not clearly defined and documented, it can be difficult to determine the compliance with this important activity. If you are conducting an audit for inspection, focus the audit on the most important aspects of managing the trial. As part of the audit, one should clearly define the audit scope and ensure that all aspects of the TMF are covered in the audit.
Suitability of Systems
Systems used to collect and store records in support of a clinical trial should be fit for purpose. For example, eTMF software used for managing the Trial Master File must have the necessary elements outlined in regulations to ensure data integrity. This includes the capability to provide an audit trail that shows actions taken, who performed them, when they were performed, and what changes were made. This allows inspectors to trace activities and monitor changes effectively.
Lack of Communication
Effective communication is vital when conducting a clinical trial. Lack of communication between teams, sponsors, CROs, and site personnel can lead to gaps in information collection and hinder effective inspections. Study Teams should establish clear lines of communication with all stakeholders, ensuring that all relevant information about the study is shared and discussed. Communication records including emails should be filed in the TMF to demonstrate transparency in activities and discussions. Relevant communications supporting study activities often occur through email. Business rules should be established between teams (sponsor/CRO) to clearly identify the responsible party for filing emails, and when they should be filed. It is good practice to restrict your email thread to a single topic to make records easier to navigate. If additional discussion points are needed, initiate a new email.
Closing the Gap: Addressing Audit Findings
Once the TMF Audit is concluded, it is crucial to address any issues identified during the review. Even if the study teams disagree with certain findings, providing documentation that supports an alternative view or engaging in discussions with the auditor can help resolve differences. We often see that audit findings are not appropriately addressed, and important findings remain unresolved before inspection occurs. Closing the gap of understanding and addressing the issues found during an audit can support meaningful conversations with the inspectorate. Log each finding with an owner, a due date, and the corrective action taken, and file that record in the TMF itself so it is retrievable during the inspection. For a view of what inspectors can expect to see, read the eTMF capabilities that keep you inspection-ready.
Spreadsheet Review vs. eTMF-Assisted Audit
How you run the audit affects how repeatable it is. The table below compares a manual, spreadsheet-based review with an audit supported by a validated eTMF. Smaller studies can reasonably start manually; programs with several studies or CROs usually outgrow it.
| Audit task | Spreadsheet or manual review | eTMF-assisted review |
|---|---|---|
| Completeness check | Compare folders to a checklist by hand | Reports against the TMF Reference Model show gaps at a glance |
| Timeliness and filing location | Reviewer opens and dates documents individually | Dates, metadata, and filing locations are queryable |
| Audit trail review | Often unavailable or partial | Automatic, uneditable audit trail |
| Access control check | Difficult to evidence | Role-based permissions can be reviewed directly |
| Tracking findings to closure | Separate tracker, easy to drift | Findings and corrective actions can be tracked and filed alongside the record |
| Repeatability across studies and CROs | Varies by reviewer | One consistent structure and process |
For more on automating the quality-control step, see automated quality control workflows in eTMF management, and for TMF fundamentals, what constitutes a Trial Master File.
Comparing eTMF Options at a Glance
If audit prep is a recurring effort, the next question is which system should hold the TMF. The table below profiles four options in the same format. It is not an independent ranking and does not assess implementation quality, market share, or fitness for any particular organization; validate each option against your own requirements, study portfolio, and inspection history.
| Option | Platform scope | Typical fit | Compliance and validation approach |
|---|---|---|---|
| Kivo eTMF | eTMF on one platform with document management, RIM, and QMS; Part 11 e-signature included | Clinical-stage biotech sponsors, from pre-IND through approval, and the CROs and partners that support them | Continuous CSA-aligned validation with each release; SOC 2 Type 2 and ISO 9001 certified |
| Veeva Vault eTMF | eTMF application within the broader Veeva Vault clinical suite | Sponsors and CROs already standardized on Veeva's clinical applications, including larger programs | Vendor-managed, validated cloud environment |
| Montrium eTMF Connect | Dedicated eTMF platform organized around the TMF Reference Model | Pharma and biotech teams evaluating a standalone eTMF outside a larger operational suite | Positioned by Montrium around inspection readiness and sponsor oversight |
| Florence eTMF | eTMF connected to Florence's site-facing eBinders platform | Sponsors and CROs prioritizing document exchange directly with investigator sites | Part 11-oriented electronic records and signatures with role-based access |
Whichever you evaluate, ask each vendor how its system handles inspector access, audit trail exports, migration in and out of the system, long-term storage pricing, and validation evidence. For a fuller checklist, see how to select an eTMF system.
How Kivo Supports Inspection-Ready TMFs
Kivo's eTMF is built so that audit preparation is a routine check rather than a scramble. Relevant capabilities include:
- Inspection readiness: inspector-specific access can be granted in minutes and shows only final document versions, organized around the TMF Reference Model so inspectors can navigate easily.
- Completeness reporting: advanced reporting and analytics let you verify TMF completeness at a glance, with built-in workflows aligned to the relevant regulations.
- Audit trails: an automatic, uneditable audit trail records actions taken, who performed them, and when.
- TMF migration: a validated process ingests documents, metadata, and audit trails from virtually any TMF platform and recompiles a single unified audit trail. Elevar Therapeutics migrated 19 TMF studies (73,794 documents) in 72 days.
- Validation handled for you: continuous CSA-aligned validation ships with every release, so your team reviews and approves evidence rather than validating the software itself.
Kivo is rated 4.9/5 on G2 and is used by 200+ sponsor, consultant, and CRO teams. To see how it works for your studies, visit the Kivo eTMF page, or read our guide to inspection readiness and trial documentation.
Frequently Asked Questions
What is a TMF audit?
A TMF audit is a systematic review of the Trial Master File to confirm that it is complete, accurate, timely, and consistent with the study's plans and regulations. It checks content quality and the processes behind it, and it is typically run before an inspection so gaps can be fixed first.
When should you conduct a TMF audit before an inspection?
Early enough to fix what you find. Many teams audit at defined study milestones and again as an inspection approaches, leaving time to close findings and re-check them. The EMA guideline expects ongoing, risk-based quality checks rather than a single review at the end of the study.
What should a TMF audit checklist include?
Whether essential documents are present, filed in the right location, added on time, correctly indexed, and role-restricted. It should also cover SOPs, oversight records, training, adherence to plans, eTMF audit trails, and evidence that earlier findings were closed.
Who should conduct a TMF audit?
A qualified person independent of the day-to-day filing, such as internal QA or an external auditor. The sponsor stays responsible for the TMF even when a CRO manages it, so the audit scope should cover CRO-held content and the oversight of the CRO.
What are the most common TMF audit findings?
Missing, late, or misfiled documents; incomplete or inconsistent records across systems; poorly defined oversight activities; unfiled email correspondence; and findings from earlier audits that were never closed. A risk-based, documented review catches most of them before inspection.
Key Takeaway
In conclusion, conducting a TMF audit is a critical step in maintaining the quality and integrity of clinical trial data and preparing for inspections. By carefully reviewing SOPs, evaluating TMF content quality, assessing oversight activities, ensuring training compliance, and interviewing study team members, organizations can enhance their inspection readiness. Avoiding common pitfalls such as incomplete or inaccurate documentation, poorly defined oversight activities, unsuitable systems, and lack of communication is essential. Finally, remembering to address the audit findings and resolving issues promptly can improve your chances of successful inspection.
If you have follow up questions regarding TMF Audits, we at Kivo are happy to help! Contact us at any time.
